α2-Adrenoceptors do not mediate neuroprotection in acute ischemic stroke in mice

Journal of Cerebral Blood Flow and Metabolism

Volumn 31, Issue 10, 2011, Pages

  Brede, Marc ^a   Braeuninger, Stefan ^a   Langhauser, Friederike ^a   Hein, Lutz ^b   Roewer, Norbert ^a   Stoll, Guido ^a   Kleinschnitz, Christoph ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

2 adrenoceptors; blood pressure; clonidine; experimental stroke; hemodynamics; neuroprotection

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; CLONIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE SEVERITY; KNOCKOUT MOUSE; MEAN ARTERIAL PRESSURE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; ANTIGENS, CD29; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CELL ADHESION; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; MEMBRANE PROTEINS; MICE; RECEPTORS, ADRENERGIC, ALPHA-2; STROKE; TIGHT JUNCTIONS;

EID: 80053564028     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2011.110     Document Type: Article

References (34)

1. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM (1986a) Evaluation of 2,3, 5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17:1304-8 (Pubitemid 17008976)
2. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H (1986b) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17:472-6 (Pubitemid 16085691)
3. Boehm S, Kubista H (2002) Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors. Pharmacol Rev 54:43-99 (Pubitemid 34208829)
4. Braeuninger S, Kleinschnitz C, Stoll G (2010) Interleukin-18 does not influence infarct volume or functional outcome in the early stage after transient focal brain ischemia in mice. Exp Transl Stroke Med 2:1
5. Brede M, Wiesmann F, Jahns R, Hadamek K, Arnolt C, Neubauer S, Lohse MJ, Hein L (2002) Feedback inhibition of catecholamine release by two different a2-adrenoceptor subtypes prevents progression of heart failure. Circulation 106:2491-6 (Pubitemid 35278807)
6. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo Jr RR, Trendelenburg U (1994) International union of pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46:121-36
7. Clark WM, Lessov NS, Dixon MP, Eckenstein F (1997) Monofilament intraluminal middle cerebral artery occlusion in the mouse. Neurol Res 19:641-8 (Pubitemid 28006649)
8. Connolly Jr ES, Winfree CJ, Stern DM, Solomon RA, Pinsky DJ (1996) Procedural and strain-related variables significantly affect outcome in a murine model of focal cerebral ischemia. Neurosurgery 38:523-31;, discussion 32
9. Cussac D, Schaak S, Denis C, Flordellis C, Calise D, Paris H (2001) High level of alpha2-adrenoceptor in rat foetal liver and placenta is due to alpha2B-subtype expression in haematopoietic cells of the erythrocyte lineage. Br J Pharmacol 133:1387-95 (Pubitemid 32783501)
10. Dirnagl U (2006) Bench to bedside: the quest for quality in experimental stroke research. J Cereb Blood Flow Metab 26:1465-78 (Pubitemid 44809076)
11. Gilsbach R, Hein L (2008) Presynaptic metabotropic receptors for acetylcholine and adrenaline/noradrena-line. Handb Exp Pharmacol 184:261-88
12. Gilsbach R, Roser C, Beetz N, Brede M, Hadamek K, Haubold M, Leemhuis J, Philipp M, Schneider J, Urbanski M, Szabo B, Weinshenker D, Hein L (2009) Genetic dissection of alpha2-adrenoceptor functions in adrenergic versus nonadrenergic cells. Mol Pharmacol 75:1160-70
13. Ginsberg MD, Becker DA, Busto R, Belayev A, Zhang Y, Khoutorova L, Ley JJ, Zhao W, Belayev L (2003) Stilbazulenyl nitrone, a novel antioxidant, is highly neuroprotective in focal ischemia. Ann Neurol 54: 330-42 (Pubitemid 37072035)
14. Globus MY, Busto R, Dietrich WD, Martinez E, Valdes I, Ginsberg MD (1988) Intra-ischemic extracellular release of dopamine and glutamate is associated with striatal vulnerability to ischemia. Neurosci Lett 91:36-40
15. Halonen T, Kotti T, Tuunanen J, Toppinen A, Miettinen R, Riekkinen PJ (1995) Alpha 2-adrenoceptor agonist, dexmedetomidine, protects against kainic acid-induced convulsions and neuronal damage. Brain Res 693: 217-24
16. Hoffman WE, Cheng MA, Thomas C, Baughman VL, Albrecht RF (1991a) Clonidine decreases plasma cate-cholamines and improves outcome from incomplete ischemia in the rat. Anesth Analg 73:460-4
17. Hoffman WE, Kochs E, Werner C, Thomas C, Albrecht RF (1991b) Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole. Anesthe-siology 75:328-32
18. Kubista H, Boehm S (2006) Molecular mechanisms underlying the modulation of exocytotic noradrenaline release via presynaptic receptors. Pharmacol Ther 112: 213-42 (Pubitemid 44301493)
19. Kuhmonen J, Haapalinna A, Sivenius J (2001) Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat. J Neural Transm 108:261-71 (Pubitemid 32703899)
20. Ma D, Hossain M, Rajakumaraswamy N, Arshad M, Sanders RD, Franks NP, Maze M (2004) Dexmedetomi-dine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur J Pharmacol 502:87-97 (Pubitemid 39311368)
21. Maier C, Steinberg GK, Sun GH, Zhi GT, Maze M (1993) Neuroprotection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia. Anesthesiology 79:306-12 (Pubitemid 23224843)
22. Palmer NI, Thomas DJ, MacGillivray BB, Du Boulay GH, Marshall J, Russell RR, Symon L (1977) Variations in mean cerebral blood flow under anesthesia at rest and during cortical activation. Stroke 8:269-71 (Pubitemid 8078371)
23. Paris A, Mantz J, Tonner PH, Hein L, Brede M, Gressens P (2006) The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the alpha2A-adrenoceptor subtype. Anesth Analg 102:456-61 (Pubitemid 43152595)
24. Philipp M, Brede M, Hein L (2002a) Physiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough. Am J Physiol Regul Integr Comp Physiol 283:R287-95 (Pubitemid 34863874)
25. Philipp M, Brede ME, Hadamek K, Gessler M, Lohse MJ, Hein L (2002b) Placental alpha(2)-adrenoceptors control vascular development at the interface between mother and embryo. Nat Genet 31:311-5
26. Philipp M, Hein L (2004) Adrenergic receptor knockout mice: distinct functions of 9 receptor subtypes. Pharmacol Ther 101:65-74 (Pubitemid 38068526)
27. Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, Volk HD, Meisel A (2003) Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by post-stroke T helper cell type 1-like immunostimulation. J Exp Med 198:725-36 (Pubitemid 37087772)
28. Schelb V, Gobel I, Khairallah L, Zhou H, Cox SL, Trendelenburg AU, Hein L, Starke K (2001) Postnatal development of presynaptic receptors that modulate noradrenaline release in mice. Naunyn Schmiedebergs Arch Pharmacol 364:359-71 (Pubitemid 32938343)
29. Shin HK, Nishimura M, Jones PB, Ay H, Boas DA, Moskowitz MA, Ayata C (2008) Mild induced hypertension improves blood flow and oxygen metabolism in transient focal cerebral ischemia. Stroke 39:1548-55
30. Stein SC, Cracco RQ (1982) Cortical injury without ischemia produced by topical monoamines. Stroke 13:74-83 (Pubitemid 12219052)
31. Stephens GJ, Mochida S (2005) G protein {beta}{gamma} subunits mediate presynaptic inhibition of transmitter release from rat superior cervical ganglion neurones in culture. J Physiol 563:765-76 (Pubitemid 40425593)
32. Trendelenburg AU, Philipp M, Meyer A, Klebroff W, Hein L, Starke K (2003) All three alpha2-adrenoceptor types serve as autoreceptors in postganglionic sympathetic neurons. Naunyn Schmiedebergs Arch Pharmacol 368:504-12 (Pubitemid 38041314)
33. Zhang Y (2004) Clonidine preconditioning decreases infarct size and improves neurological outcome from transient forebrain ischemia in the rat. Neuroscience 125:625-31 (Pubitemid 38510172)
34. Zhu QM, Lesnick JD, Jasper JR, MacLennan SJ, Dillon MP, Eglen RM, Blue Jr DR (1999) Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic mice. Br J Pharmacol 126:1522-30 (Pubitemid 29142085)